BioXcel Therapeutics Inc (NASDAQ:BTAI)’s traded shares stood at 0.62 million during the last session, with the company’s beta value hitting 0.42. At the close of trading, the stock’s price was $2.75, to imply an increase of 7.84% or $0.2 in intraday trading. The BTAI share’s 52-week high remains $29.56, putting it -974.91% down since that peak but still an impressive 30.55% since price per share fell to its 52-week low of $1.91. The company has a valuation of $92.48M, with an average of 1.53 million shares over the past 3 months.

BioXcel Therapeutics Inc (NASDAQ:BTAI) trade information

After registering a 7.84% upside in the last session, BioXcel Therapeutics Inc (BTAI) has traded red over the past five days. The stock hit a weekly high of 2.97, jumping 7.84% in its intraday price action. The 5-day price performance for the stock is -5.17%, and -1.08% over 30 days. With these gigs, the year-to-date price performance is -6.78%.

BioXcel Therapeutics Inc (BTAI) estimates and forecasts

Looking at statistics comparing BioXcel Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. BioXcel Therapeutics Inc (BTAI) shares are 2.61% up over the last 6 months, with its year-to-date growth rate higher than industry average at 60.00% against 13.30%.

BTAI Dividends

BioXcel Therapeutics Inc has its next earnings report out between May 06 and May 10. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. BioXcel Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.